Etzer Darout
Stock Analyst at Barclays
(4.95)
# 135
Out of 5,004 analysts
528
Total ratings
59.4%
Success rate
30.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics | Maintained: Buy | $53 | $33.51 | +58.16% | 9 | Sep 23, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $75 | $53.92 | +39.09% | 14 | Sep 23, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $148 | $98.29 | +50.57% | 12 | Sep 22, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $160 | $94.55 | +69.22% | 9 | Sep 21, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | $18 | $17.12 | +5.14% | 13 | Sep 21, 2026 | |
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $13 → $15 | $10.64 | +40.98% | 13 | Sep 17, 2026 | |
| SRRK Scholar Rock Holding | Downgraded: Hold | $55 → $58 | $51.19 | +13.30% | 21 | Sep 14, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $78 → $74 | $18.64 | +297.00% | 12 | Sep 11, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $128 → $145 | $96.63 | +50.06% | 10 | Sep 11, 2026 | |
| XNCR Xencor | Reiterated: Buy | $27 → $35 | $25.16 | +39.11% | 33 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 → $271 | $240.57 | +12.65% | 8 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $11.73 | +138.70% | 15 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $407 → $415 | $368.08 | +12.75% | 10 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $41.03 | +58.42% | 6 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 → $180 | $145.07 | +24.08% | 12 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $1.57 | +91.08% | 10 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $78 | $48.19 | +61.86% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $4.12 | +45.63% | 34 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.31 | +111.48% | 30 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $13.44 | +108.33% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $2.94 | +444.22% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 | $17.47 | -19.86% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $30 | $19.35 | +55.04% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 | $58.15 | -15.74% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.50 | +160.87% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.51 | +135.02% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $18.19 | +103.46% | 15 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $134 → $139 | $126.93 | +9.51% | 17 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $119 | $122.06 | -2.51% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.65 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $143 | $100.87 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.15 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.58 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.24 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.22 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.67 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $141.28 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.57 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.6229 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $37 | $91.39 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.000001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $0.50 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $25 | $7.78 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $3.68 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €22.73 → €26.23 | €3.07 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $251.65 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $27.57 | n/a | 4 | Jul 14, 2020 |
Celldex Therapeutics
Sep 23, 2026
Maintained: Buy
Price Target: $53
Current: $33.51
Upside: +58.16%
AnaptysBio
Sep 23, 2026
Maintained: Buy
Price Target: $75
Current: $53.92
Upside: +39.09%
ABIVAX Société Anonyme
Sep 22, 2026
Reiterated: Buy
Price Target: $148
Current: $98.29
Upside: +50.57%
Oruka Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $160
Current: $94.55
Upside: +69.22%
Summit Therapeutics
Sep 21, 2026
Reiterated: Hold
Price Target: $18
Current: $17.12
Upside: +5.14%
Iovance Biotherapeutics
Sep 17, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $10.64
Upside: +40.98%
Scholar Rock Holding
Sep 14, 2026
Downgraded: Hold
Price Target: $55 → $58
Current: $51.19
Upside: +13.30%
Legend Biotech
Sep 11, 2026
Reiterated: Buy
Price Target: $78 → $74
Current: $18.64
Upside: +297.00%
Monopar Therapeutics
Sep 11, 2026
Reiterated: Buy
Price Target: $128 → $145
Current: $96.63
Upside: +50.06%
Xencor
Sep 11, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $25.16
Upside: +39.11%
Sep 10, 2026
Reiterated: Buy
Price Target: $270 → $271
Current: $240.57
Upside: +12.65%
Sep 10, 2026
Reiterated: Buy
Price Target: $28
Current: $11.73
Upside: +138.70%
Sep 10, 2026
Reiterated: Buy
Price Target: $407 → $415
Current: $368.08
Upside: +12.75%
Sep 3, 2026
Reiterated: Buy
Price Target: $65
Current: $41.03
Upside: +58.42%
Aug 31, 2026
Reiterated: Buy
Price Target: $153 → $180
Current: $145.07
Upside: +24.08%
Aug 20, 2026
Reiterated: Sell
Price Target: $3
Current: $1.57
Upside: +91.08%
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $78
Current: $48.19
Upside: +61.86%
Aug 14, 2026
Reiterated: Buy
Price Target: $6
Current: $4.12
Upside: +45.63%
Aug 12, 2026
Reiterated: Buy
Price Target: $7
Current: $3.31
Upside: +111.48%
Aug 7, 2026
Reiterated: Buy
Price Target: $28
Current: $13.44
Upside: +108.33%
Aug 7, 2026
Reiterated: Buy
Price Target: $16
Current: $2.94
Upside: +444.22%
Aug 7, 2026
Reiterated: Sell
Price Target: $14
Current: $17.47
Upside: -19.86%
Aug 7, 2026
Reiterated: Buy
Price Target: $27 → $30
Current: $19.35
Upside: +55.04%
Aug 6, 2026
Reiterated: Hold
Price Target: $49
Current: $58.15
Upside: -15.74%
Aug 6, 2026
Reiterated: Buy
Price Target: $30
Current: $11.50
Upside: +160.87%
Aug 5, 2026
Reiterated: Buy
Price Target: $20
Current: $8.51
Upside: +135.02%
Aug 5, 2026
Reiterated: Buy
Price Target: $37
Current: $18.19
Upside: +103.46%
Jul 28, 2026
Reiterated: Buy
Price Target: $134 → $139
Current: $126.93
Upside: +9.51%
Dec 8, 2025
Reiterated: Buy
Price Target: $70 → $119
Current: $122.06
Upside: -2.51%
Apr 4, 2025
Reiterated: Buy
Price Target: $9
Current: $3.65
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $130 → $143
Current: $100.87
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.15
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.58
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $4.24
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $35.22
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $25.67
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $141.28
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $10.57
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.6229
Upside: n/a
Sep 13, 2021
Reiterated: Buy
Price Target: $38 → $37
Current: $91.39
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $0.50
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $16 → $25
Current: $7.78
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $3.68
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: €22.73 → €26.23
Current: €3.07
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $251.65
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: $48
Current: $27.57
Upside: n/a